Three countries with different systems achieved similar levels of control, indicating that efforts to lessen CV risk should ...

Experts hope the FAI score can become the next big tool in personalized risk assessment, though costs remain unknown.

The 2026 dyslipidemia guidelines offer “a chance to save lives at scale.” But statins alone can’t solve the problem.

With expectations to work after hours and a growing administrative burden, some say “radical” action is needed.

The Centers for Medicare & Medicaid Services is weighing whether to cover TAVI in asymptomatic severe aortic stenosis, as ...

Absent contraindications, optimal medical therapy for heart failure with preserved ejection fraction (HFpEF) should include a ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Ami Bhatt and Jagat Narula discuss the global impact of rheumatic heart disease, its challenges, and ongoing efforts for ...

Twenty years of data from New England highlight geographical challenges, which some say may merit a rethink of STEMI care.

This month: online GLP-1 concerns, psychological impact of wearables, sexual and gender minority health insights, and more.

More than half of US adults are eligible for primary prevention with statins, yet lipid-lowering therapies remain underused.

As the researchers saw no link between elevated Lp (a) and VTE risk in men or postmenopausal women not on hormone therapy, the findings indicate that sex hormones may play a greater role than ...